Because Microdosing GLP-1 uses a lower dose of Semaglutide, it may be associated with a lower likelihood and severity of side effects compared to standard doses. Possible side effects are expected to be similar to other Semaglutide medications and can include nausea, diarrhea, constipation, abdominal pain, headache, and fatigue. Most side effects are temporary and may resolve within a few days to a few weeks—if they persist or worsen, contact your provider.

Microdose GLP-1 may be an option for adults interested in supporting overall wellness, healthy aging, or metabolic health with a gentler approach than standard GLP-1 doses. It may be considered for individuals who are sensitive to higher doses or want to potentially minimize side effects. Your provider can help determine if microdosing is appropriate based on your health history and goals.

Microdose GLP-1 uses a much lower dose than standard treatments. This gentler approach may be associated with supporting cognitive function, inflammation response, energy levels, as well as healthy aging. Lower doses may also help reduce the likelihood and intensity of side effects.